- The trend backdrop is active with a 2-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
ALPA
NSI
Week ended 07 Aug 2026
Weekly Investor Report
Alpa Laboratories Limited · Healthcare · Drug Manufacturers - Specialty & Generic
Latest close
68.09 INR
1.9%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is 2.1% above the Trend Line and sits at 40.1% of its 52-week range. The latest completed week returned 1.9%, after a -0.2% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 51/100.
Setup score
38
out of 100
Latest Close
68.09 INR
7 Aug 2026
1W Return
1.9%
latest completed week
4W Return
-0.2%
short-term follow-through
12W Return
-3.8%
quarterly tape
Trend Breadth
3.8%
2 of 52 weeks active
Volume Ratio
2.1x
vs 13-week average
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 39.89% based on similar historical setup states.
- Activity pressure is weak, so confirmation is not yet broad enough.
- The share remains more than 20% below its 52-week high.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
1.9%
Latest completed week; four-week move -0.2%.
Indicator stack
9/50
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 39.89%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
51/100
9 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 2.1% above the Trend Line and sits at 40.1% of its 52-week range. The latest completed week returned 1.9%, after a -0.2% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 2.1x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.2412-week average 0.27
12-week confirmation
Trend active2/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.24Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -0.2% over four weeks, -3.8% over 12 weeks, and -29.3% over one year. The current trend has remained active for 2 consecutive weeks.
Performance by holding period
Active trend streak2 weeks
Active weeks in one year2
Trend breadth3.8%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.27Latest activity-pressure read.
Pressure change-63.0%Four-week change in activity pressure.
Leadership-8.47Latest relative-leadership reading.
RS change13.2%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 91%
Model confidence 85%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength73/100Blend of value, momentum, and quality. Underlying universe rank 28; rank 1 is best.
Value59/100Relative valuation strength. Underlying universe rank 42; rank 1 is best.
Quality58/100Profitability and accounting quality. Underlying universe rank 43; rank 1 is best.
Momentum61/100Medium-term price momentum. Underlying universe rank 40; rank 1 is best.
Growth58/100Revenue and earnings growth. Underlying universe rank 43; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 9.4x Price divided by trailing earnings.
- Price / sales
- 1.4x Market value relative to trailing revenue.
- EV / EBITDA
- 7.6x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 4.1% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 29.8% Gross profit retained from each unit of revenue.
- Operating margin
- 1.1% Operating profit retained from revenue.
- Free-cash-flow margin
- 5.7% Free cash flow generated from revenue.
- Return on invested capital
- 0.5% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- -5.9% Latest one-year revenue growth.
- EPS growth
- -23.0% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- - Latest one-year free-cash-flow growth.
- Piotroski F-score
- 3/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- 0.0% Net share repurchases relative to market value.
- Shareholder yield
- 0.0% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 0.1x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment51/100
Weighted news tone is neutral across 9 relevant articles.
1 positive · 7 neutral · 1 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-32.6%Distance below the 52-week high.
13-week volatility1.8%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher9 of 2617 weeks finished lower.
Best week+33.4%Week of 10 Apr.
Worst week-14.2%Week of 27 Mar.
Latest week+1.9%Week of 7 Aug.
Shape of recent returns
Strong gains2
Modest gains7
Flat weeks0
Modest losses14
Sharp losses3
Recent vol1.8%13-week weekly-return volatility.
Base vol6.3%52-week weekly-return volatility.
Up/down split19/33Count of positive and negative weeks in the 52-week window.
Average skew4.3% / -3.2%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIN Healthcare
4-week rank- / 100
Group average1.2%
Trend breadth83.0%
Trend83.0%active weekly trend signals
MD85.0%positive activity pressure
RS73.0%positive relative leadership
Four-week leaders
IndustryIN Drug Manufacturers - Specialty & Generic
4-week rank41 / 92
Group average1.0%
Trend breadth76.1%
Trend76.1%active weekly trend signals
MD80.4%positive activity pressure
RS65.2%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape34/100
Trend, activity pressure, participation, and risk combine to a 34/100 tape read.
Indicator analysis38/100Latest 12-week confirmation: trend 2/12, activity pressure 12/12, relative leadership 0/12.
Activity pressure 0.24; No reversal markers Next-Week ExpectancyNegative 39.89%Next-week expectancy is negative with a 39.89% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors62/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 8 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment51/100Weighted news tone is neutral across 9 relevant articles.
Alpa Laboratories Limited Revenue Breakdown – BSE:ALPA Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 68.09 INR | 1.9% | 66.67 INR | 91.79 INR | 0.27 | -8.47 | 114.0K | On |
| 31 Jul 2026 | 66.84 INR | -0.5% | 66.91 INR | 91.84 INR | 0.37 | -10.13 | 44.9K | On |
| 24 Jul 2026 | 67.17 INR | -1.9% | 67.29 INR | 91.91 INR | 0.57 | -8.06 | 33.0K | Off |
| 17 Jul 2026 | 68.49 INR | 0.4% | 67.59 INR | 91.92 INR | 0.73 | -9.17 | 223.5K | Off |
| 10 Jul 2026 | 68.25 INR | -0.7% | 67.87 INR | 91.93 INR | 0.72 | -9.76 | 37.4K | Off |
| 3 Jul 2026 | 68.72 INR | 0.3% | 68.28 INR | 91.94 INR | 0.69 | -10.10 | 5.1K | Off |
| 26 Jun 2026 | 68.50 INR | 0.6% | 68.70 INR | 91.96 INR | 0.66 | -10.24 | 0 | Off |
| 19 Jun 2026 | 68.11 INR | -2.3% | 69.03 INR | 91.97 INR | 0.75 | -11.17 | 20.2K | Off |
| 12 Jun 2026 | 69.69 INR | 1.1% | 69.38 INR | 91.96 INR | 0.78 | -8.18 | 18.2K | Off |
| 5 Jun 2026 | 68.92 INR | -3.5% | 69.92 INR | 91.92 INR | 0.82 | -8.78 | 14.3K | Off |
| 29 May 2026 | 71.42 INR | 3.3% | 70.33 INR | 91.88 INR | 0.90 | -6.75 | 96.8K | Off |
| 22 May 2026 | 69.16 INR | -2.2% | 71.00 INR | 91.81 INR | 0.86 | -10.87 | 39.6K | Off |
| 15 May 2026 | 70.75 INR | -0.0% | 71.67 INR | 91.76 INR | 0.87 | -9.30 | 75.6K | Off |
| 8 May 2026 | 70.76 INR | 6.9% | 72.25 INR | 91.68 INR | 0.84 | -11.98 | 74.6K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.